VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+20.43%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$869M
AUM Growth
+$869M
(-4.1%)
Cap. Flow
-$44.8M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
62.94%
Holding
54
New
3
Increased
9
Reduced
7
Closed
6
Top Buys
| 1 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$20.2M |
| 2 |
Astria Therapeutics
ATXS
|
$10.1M |
| 3 |
Geron
GERN
|
$9.79M |
| 4 |
Vaxcyte
PCVX
|
$8.39M |
| 5 |
Compass Therapeutics
CMPX
|
$7.83M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$43.8M |
| 2 |
Relmada Therapeutics
RLMD
|
$26.4M |
| 3 |
Ascendis Pharma
ASND
|
$15.1M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$8.67M |
| 5 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$7.39M |
Sector Composition
| 1 | Healthcare | 98.63% |
| 2 | Materials | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Harmony Biosciences
HRMY
$2.12B
| $144M | 16.53% | 2,606,247 -794,014 | -23% | -$43.8M |
|
2
Terns Pharmaceuticals
TERN
$609M
| $67.8M | 7.8% | 6,657,992 +758,620 | +13% | +$7.72M |
|
3
Viridian Therapeutics
VRDN
$1.5B
| $49M | 5.64% | 1,678,207 +18,188 | +1% | +$531K |
|
4
ALX Oncology
ALXO
$62.7M
| $47.6M | 5.48% | 4,220,048 | – | – |
|
|
5
Geron
GERN
$893M
| $46.7M | 5.37% | 19,282,834 +4,044,739 | +27% | +$9.79M |
|
|
IMPL
6
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $43.3M | 4.98% | 2,884,789 | – | – |
|
7
Ventyx Biosciences
VTYX
$171M
| $42.7M | 4.92% | 1,303,294 -52,567 | -4% | -$1.72M |
|
|
SVA
8
DELISTED
Sinovac Biotech, Ltd
SVA
| $38.2M | 4.4% | 5,900,000 | – | – |
|
|
ALLK
9
DELISTED
Allakos
ALLK
| $34.7M | 3.99% | 4,120,134 | – | – |
|
10
Tarsus Pharmaceuticals
TARS
$2.47B
| $33.2M | 3.82% | 2,262,200 | – | – |
|
|
11
Vaxcyte
PCVX
$4B
| $27.8M | 3.2% | 579,508 +175,000 | +43% | +$8.39M |
|
|
12
Astria Therapeutics
ATXS
$349M
| $25M | 2.88% | 1,681,199 +681,199 | +68% | +$10.1M |
|
13
Cogent Biosciences
COGT
$1.69B
| $23.1M | 2.66% | 1,994,941 +111,000 | +6% | +$1.28M |
|
|
KDNY
14
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $22.9M | 2.63% | 872,151 | – | – |
|
|
VECT
15
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $20.2M | 2.33% | +2,333,300 | New | +$20.2M |
|
|
AVDL
16
Avadel Pharmaceuticals
AVDL
$1.43B
| $19.7M | 2.27% | 2,754,095 -182,998 | -6% | -$1.31M |
|
|
17
Compass Therapeutics
CMPX
$483M
| $17.9M | 2.06% | 3,557,630 +1,557,630 | +78% | +$7.83M |
|
18
Aclaris Therapeutics
ACRS
$209M
| $14.2M | 1.63% | 898,631 | – | – |
|
19
Legend Biotech
LEGN
$6.41B
| $12.2M | 1.4% | 244,375 | – | – |
|
|
AMRS
20
DELISTED
Amyris Inc.
AMRS
| $11.9M | 1.37% | 7,750,828 | – | – |
|
21
Zai Lab
ZLAB
$3.68B
| $10.4M | 1.2% | 338,721 +67,193 | +25% | +$2.06M |
|
|
GTH
22
DELISTED
Genetron Holdings Limited ADS
GTH
| $9.1M | 1.05% | 8,124,174 | – | – |
|
|
BLU
23
DELISTED
BELLUS Health Inc.
BLU
| $8.36M | 0.96% | 1,017,152 | – | – |
|
24
Instil Bio
TIL
$182M
| $7.87M | 0.91% | 12,486,787 | – | – |
|
25
Vera Therapeutics
VERA
$1.38B
| $7.75M | 0.89% | 400,666 -266,000 | -40% | -$5.15M |
|